Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis
Open Access
- 21 February 2021
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (4) , 879
Abstract
Background: Survivin belongs to the protein family of inhibitors of apoptosis (IAP) and is a regulator of the cell cycle and apoptosis. The aim of this study was to assess the clinical and prognostic significance of expression survivin in patients with ovarian cancer. Methods: We systematically searched for articles in PubMed, the American Chemical Society (Publications), Medline, the Royal Society of Chemistry, Scopus and the Web of Science. Patient clinical data, overall survival (OS), disease-free survival (DFS), and survivin expression were extracted from individual studies. We performed statistical analysis using the STATA 16 package. Eighteen publications containing data from 2233 patients with ovarian cancer were included in this meta-analysis. Results: We found an adverse effect of survivin expression on OS (risk ratio (HR): 1.60; 95% confidence interval (CI): 1.33–1.93, p = 0.00) but this was not observed on DFS (HR: 1.06; 95% CI: 0.55–2.05, p = 0.87). The analysis of clinicopathological parameters showed that survivin expression was associated with the histological grades (G1–2 vs. G3) (odds ratio (OR) = 0.53, 95% CI: 0.34–0.83, p = 0.01) and: International Federation Gynecology and Obstetrics (FIGO) stage (I–II vs. III–IV) (OR = 0.22, 95% CI: 0.09–0.55, p = 0.00), but it was not significantly correlated with the histological subtype (OR = 1.14, 95% CI: 0.83–1.58, p = 0.42). Conclusions: Our meta-analysis suggests that survivin expression may be a marker of poor prognosis in ovarian cancer. Survivin expression was associated with parameters of greater aggressiveness of ovarian cancer. Prospective studies are needed to confirm our results indicating that survivin expression can be used as an ovarian cancer biomarker.Keywords
This publication has 53 references indexed in Scilit:
- Survivin Status Affects Prognosis and Chemosensitivity in Epithelial Ovarian CancerInternational Journal of Gynecological Cancer, 2013
- Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patientsJournal of Ovarian Research, 2011
- Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry dataThe Lancet, 2011
- Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signalingMolecular Carcinogenesis, 2009
- Are Serum Protein Biomarkers Effective in Detecting Ovarian Cancer in Its Early Stages?Clinical Journal of Oncology Nursing, 2009
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinomaCancer, 2007
- Cellular response to chemotherapy and radiation in cervical cancerAmerican Journal of Obstetrics and Gynecology, 2005
- Survivin Expression in Ovarian Carcinoma: Correlation with Apoptotic Markers and PrognosisLaboratory Investigation, 2003
- Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinomaCancer, 2003